Literature DB >> 23027626

Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models.

Daiana D Becker-Santos1, Yubin Guo, Mazyar Ghaffari, Elaine D Vickers, Melanie Lehman, Manuel Altamirano-Dimas, Arusha Oloumi, Junya Furukawa, Manju Sharma, Yuzhuo Wang, Shoukat Dedhar, Michael E Cox.   

Abstract

Approximately half of prostate cancers (PCa) carry TMPRSS2-ERG translocations; however, the clinical impact of this genomic alteration remains enigmatic. Expression of v-ets erythroblastosis virus E26 oncogene like (avian) gene (ERG) promotes prostatic epithelial dysplasia in transgenic mice and acquisition of epithelial-to-mesenchymal transition (EMT) characteristics in human prostatic epithelial cells (PrECs). To explore whether ERG-induced EMT in PrECs was associated with therapeutically targetable transformation characteristics, we established stable populations of BPH-1, PNT1B and RWPE-1 immortalized human PrEC lines that constitutively express flag-tagged ERG3 (fERG). All fERG-expressing populations exhibited characteristics of in vitro and in vivo transformation. Microarray analysis revealed >2000 commonly dysregulated genes in the fERG-PrEC lines. Functional analysis revealed evidence that fERG cells underwent EMT and acquired invasive characteristics. The fERG-induced EMT transcript signature was exemplified by suppressed expression of E-cadherin and keratins 5, 8, 14 and 18; elevated expression of N-cadherin, N-cadherin 2 and vimentin, and of the EMT transcriptional regulators Snail, Zeb1 and Zeb2, and lymphoid enhancer-binding factor-1 (LEF-1). In BPH-1 and RWPE-1-fERG cells, fERG expression is correlated with increased expression of integrin-linked kinase (ILK) and its downstream effectors Snail and LEF-1. Interfering RNA suppression of ERG decreased expression of ILK, Snail and LEF-1, whereas small interfering RNA suppression of ILK did not alter fERG expression. Interfering RNA suppression of ERG or ILK impaired fERG-PrEC Matrigel invasion. Treating fERG-BPH-1 cells with the small molecule ILK inhibitor, QLT-0267, resulted in dose-dependent suppression of Snail and LEF-1 expression, Matrigel invasion and reversion of anchorage-independent growth. These results suggest that ILK is a therapeutically targetable mediator of ERG-induced EMT and transformation in PCa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027626      PMCID: PMC3510737          DOI: 10.1093/carcin/bgs285

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  57 in total

1.  Snail1 is over-expressed in prostate cancer.

Authors:  Sara Heebøll; Michael Borre; Peter David Ottosen; Lars Dyrskjøt; Torben Falck Orntoft; Niels Tørring
Journal:  APMIS       Date:  2009-03       Impact factor: 3.205

2.  Delineation of TMPRSS2-ERG splice variants in prostate cancer.

Authors:  Ying Hu; Albert Dobi; Taduru Sreenath; Christopher Cook; Atekelt Y Tadase; Lakshmi Ravindranath; Jennifer Cullen; Bungo Furusato; Yongmei Chen; Rajesh L Thangapazham; Ahmed Mohamed; Chen Sun; Isabell A Sesterhenn; David G McLeod; Gyorgy Petrovics; Shiv Srivastava
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

3.  LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.

Authors:  Yirong Li; Longgui Wang; Miao Zhang; Jonathan Melamed; Xiaomei Liu; Robert Reiter; Jianjun Wei; Yi Peng; Xuanyi Zou; Angel Pellicer; Michael J Garabedian; Anna Ferrari; Peng Lee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

4.  Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.

Authors:  Brett S Carver; Jennifer Tran; Anuradha Gopalan; Zhenbang Chen; Safa Shaikh; Arkaitz Carracedo; Andrea Alimonti; Caterina Nardella; Shohreh Varmeh; Peter T Scardino; Carlos Cordon-Cardo; William Gerald; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2009-04-26       Impact factor: 38.330

Review 5.  Integrin-linked kinase--essential roles in physiology and cancer biology.

Authors:  Paul C McDonald; Andrew B Fielding; Shoukat Dedhar
Journal:  J Cell Sci       Date:  2008-10-01       Impact factor: 5.285

6.  Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome.

Authors:  Maisa Yoshimoto; Anthony M Joshua; Isabela W Cunha; Renata A Coudry; Francisco P Fonseca; Olga Ludkovski; Maria Zielenska; Fernando A Soares; Jeremy A Squire
Journal:  Mod Pathol       Date:  2008-05-23       Impact factor: 7.842

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Integrin-linked kinase regulates E-cadherin expression through PARP-1.

Authors:  Timothy R McPhee; Paul C McDonald; Arusha Oloumi; Shoukat Dedhar
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

9.  Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.

Authors:  Jennifer C King; Jin Xu; John Wongvipat; Haley Hieronymus; Brett S Carver; David H Leung; Barry S Taylor; Chris Sander; Robert D Cardiff; Suzana S Couto; William L Gerald; Charles L Sawyers
Journal:  Nat Genet       Date:  2009-04-26       Impact factor: 38.330

10.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.

Authors:  Liesel M FitzGerald; Ilir Agalliu; Karynn Johnson; Melinda A Miller; Erika M Kwon; Antonio Hurtado-Coll; Ladan Fazli; Ashish B Rajput; Martin E Gleave; Michael E Cox; Elaine A Ostrander; Janet L Stanford; David G Huntsman
Journal:  BMC Cancer       Date:  2008-08-11       Impact factor: 4.430

View more
  27 in total

1.  LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.

Authors:  Jiaqian Liang; Yirong Li; Garrett Daniels; Karen Sfanos; Angelo De Marzo; Jianjun Wei; Xin Li; Wenqiang Chen; Jinhua Wang; Xuelin Zhong; Jonathan Melamed; Jun Zhao; Peng Lee
Journal:  Mol Cancer Res       Date:  2015-01-13       Impact factor: 5.852

Review 2.  Cell mates: paracrine and stromal targets for prostate cancer therapy.

Authors:  Pavel Sluka; Ian D Davis
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

3.  Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway.

Authors:  Yayuan Yu; Wencheng Liu; Xinlu Zhan; Yanying Zhong; Ying Feng; Qing Cao; Buzhen Tan
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 4.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

5.  microRNAs and Prostate Cancer.

Authors:  Sajni Josson; Leland W K Chung; Murali Gururajan
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.

Authors:  Sajni Josson; Murali Gururajan; Peizhen Hu; Chen Shao; GinaChia-Yi Chu; Haiyen E Zhau; Chunyan Liu; Kaiqin Lao; Chia-Lun Lu; Yi-Tsung Lu; Jake Lichterman; Srinivas Nandana; Quanlin Li; Andre Rogatko; Dror Berel; Edwin M Posadas; Ladan Fazli; Dhruv Sareen; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

7.  Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.

Authors:  Hong Shen; Jun-Li Ma; Yan Zhang; Gan-Lu Deng; Yan-Ling Qu; Xiao-Ling Wu; Jing-Xuan He; Sai Zhang; Shan Zeng
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

8.  Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Authors:  Michael C Haffner; Christopher Weier; Meng Meng Xu; Ajay Vaghasia; Bora Gürel; Berrak Gümüşkaya; David M Esopi; Helen Fedor; Hsueh-Li Tan; Ibrahim Kulac; Jessica Hicks; William B Isaacs; Tamara L Lotan; William G Nelson; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

9.  ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.

Authors:  Longtao Wu; Jonathan C Zhao; Jung Kim; Hong-Jian Jin; Cun-Yu Wang; Jindan Yu
Journal:  Cancer Res       Date:  2013-08-01       Impact factor: 12.701

10.  High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.

Authors:  Nathaniel Melling; Levon Harutyunyan; Claudia Hube-Magg; Martina Kluth; Ronald Simon; Patrick Lebok; Sarah Minner; Maria Christina Tsourlakis; Christina Koop; Markus Graefen; Meike Adam; Alexander Haese; Corinna Wittmer; Stefan Steurer; Jakob Izbicki; Guido Sauter; Waldemar Wilczak; Thorsten Schlomm; Till Krech
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.